Home Medicine Reference change values and power functions
Article
Licensed
Unlicensed Requires Authentication

Reference change values and power functions

  • Natàlia Iglesias Canadell , Per Hyltoft Petersen , Esther Jensen , Carmen Ricós and Per E. Jørgensen
Published/Copyright: June 1, 2005

Abstract

Repeated samplings and measurements in the monitoring ofpatients to look for changes are common clinical problems. The “reference change value”, calculated as zP×[2×(CVI2 + CVA2)]1/2, where zP is the z-statistic and CVI and CVA are within-subject and analytical coefficients of variation, respectively, has been used to detect whether a measured difference between measurements is statistically significant. However, a reference change value only detects the probability of false-positives (type I error), and for this reason, a model to calculate the risk ofmissing significant changes in serial results from individuals (probability off alse-negatives) is investigated in this work by means of power functions. Therefore, when an analyte is being monitored in a patient, power functions estimate the probability of detecting a defined real change by measuring the difference. Thus, when a measured difference is the same as the calculated reference change value, then it will be detected in only 50% of situations.

Published Online: 2005-6-1
Published in Print: 2004-4-5

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. How useful are haematology analyser flags?
  2. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders
  3. Automated flagging influences the inconsistency and bias of band cell and atypical lymphocyte morphological differentials
  4. Extracellular concentration of homocysteine in human cell lines is influenced by specific inhibitors of cyst(e)ine transport
  5. Generation of eight adjacent mutations in a single step using a site-directed mutagenesis kit
  6. Prohepcidin accumulates in renal insufficiency
  7. Impurities from polypropylene microcentrifuge tubes as a potential source of interference in simultaneous analysis of multiple lipid-soluble antioxidants by HPLC with electrochemical detection
  8. Cerebrospinal fluid tau and Aβ42 concentrations in healthy subjects: delineation of reference intervals and their limitations
  9. The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers
  10. Reference change values and power functions
  11. A different approach to analyzing age-related HbA1c values in non-diabetic subjects
  12. Ratio of urinary free immunoglobulin light chain κ to λ in the diagnosis of Bence Jones proteinuria
  13. Influence of blood collection in plastic vs. glass evacuated serum-separator tubes on hormone and tumour marker levels
  14. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor® System
  15. Comparison of three commercial assays for the measurement of 17α-hydroxyprogesterone (17α-OHPR): limitations of the quality control system
  16. Analytical performance of the Albumin Cobalt Binding (ACB®) test on the Cobas MIRA® Plus analyzer
  17. Letter to the Editor
  18. Meetings and Awards
Downloaded on 9.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.073/html
Scroll to top button